These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3485840)

  • 1. Modulation of cellular and humoral immune responses by O,S,S-trimethyl phosphorodithioate, an impurity of commercial malathion.
    Thomas IK; Imamura T
    Toxicology; 1986 Apr; 39(1):1-12. PubMed ID: 3485840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute administration of O,S,S-trimethyl phosphorodithioate on the generation of cellular and humoral immune responses following in vitro stimulation.
    Rodgers KE; Leung N; Ware CF
    Toxicology; 1988 Oct; 51(2-3):241-53. PubMed ID: 3051516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive effect of an impurity of malathion: inhibition of murine T- and B-lymphocyte responses by O,O,S-trimethyl phosphorothioate.
    Thomas IK; Imamura T
    Toxicol Appl Pharmacol; 1986 May; 83(3):456-64. PubMed ID: 2939594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive effect of O,O-dimethyl, S-ethyl phosphorothioate on immune response.
    Thomas IK; Koizumi A; Imamura T
    J Toxicol Environ Health; 1986; 19(4):465-76. PubMed ID: 3491217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of subacute administration of O,S,S-trimethyl phosphorodithioate on cellular and humoral immune response systems.
    Rodgers KE; Stern ML; Ware CF
    Toxicology; 1989 Feb; 54(2):183-95. PubMed ID: 2784238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of O,S,S-trimethyl phosphorodithioate on immune function.
    Rodgers KE; Leung N; Ware CF; Imamura T
    Toxicology; 1987 Feb; 43(2):201-16. PubMed ID: 3492784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of subchronic treatment with O,O,S-trimethyl phosphorothioate on cellular and humoral immune response systems.
    Rodgers KE; Imamura T; Devens BH
    Toxicol Appl Pharmacol; 1985 Nov; 81(2):310-8. PubMed ID: 3877352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung injury and delayed toxicity produced by O,S,S-trimethyl phosphorodithioate, an impurity of malathion.
    Konno N; Fukuto TR; Imamura T
    Toxicol Appl Pharmacol; 1984 Sep; 75(2):219-28. PubMed ID: 6474459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organophosphorus pesticide immunotoxicity: effects of O,O,S-trimethyl phosphorothioate on cellular and humoral immune response systems.
    Rodgers KE; Imamura T; Devens BH
    Immunopharmacology; 1986 Dec; 12(3):193-202. PubMed ID: 3493228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cytotoxic T lymphocyte and natural killer cell-mediated lysis by O,S,S,-trimethyl phosphorodithioate is at an early postrecognition step.
    Rodgers KE; Grayson MH; Ware CF
    J Immunol; 1988 Jan; 140(2):564-70. PubMed ID: 3257244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate: generation of suppressive macrophages from treated animals.
    Rodgers KE; Imamura T; Devens BH
    Toxicol Appl Pharmacol; 1987 Apr; 88(2):270-81. PubMed ID: 3494328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver damage induced in rats by malathion impurities.
    Keadtisuke S; Dheranetra W; Nakatsugawa T; Fukuto TR
    Toxicol Lett; 1990 Jun; 52(1):35-46. PubMed ID: 2356569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phencyclidine exposure alters in vitro cellular immune response parameters associated with host defense.
    Thomas PT; House RV; Bhargava HN
    Life Sci; 1993; 53(18):1417-27. PubMed ID: 8231630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trialkyl phosphorothioates and glutathione S-transferases.
    Aldridge WN; Grasdalen H; Aarstad K; Street BW; Norkov T
    Chem Biol Interact; 1985 Jul; 54(2):243-56. PubMed ID: 4028290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of humoral and cellular immunity by soluble mediators after 5-fluorouracil-induced immunosuppression.
    Merluzzi VJ; Last-Barney K; Susskind BM; Faanes RB
    Clin Exp Immunol; 1982 Nov; 50(2):318-26. PubMed ID: 6217933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate. I. Characterization of the immune cell population affected.
    Rodgers KE; Imamura T; Devens BH
    Immunopharmacology; 1985 Dec; 10(3):171-80. PubMed ID: 2939039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of two bisdioxopiperazines on mouse B-and T-cell function.
    Dennert G; Hatlen LE; Tucker DF
    J Natl Cancer Inst; 1975 Mar; 54(3):621-9. PubMed ID: 804564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations into the mechanism of immunosuppression caused by acute treatment with O,O,S-trimethyl phosphorothioate. II. Effect on the ability of murine macrophages to present antigen.
    Rodgers KE; Imamura T; Devens BH
    Immunopharmacology; 1985 Dec; 10(3):181-9. PubMed ID: 3833856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic immunosuppression following a single pharyngeal aspiration of 1,2:5,6-dibenzanthracene in female B6C3F1 mice.
    Smith DC; Smith MJ; White KL
    J Immunotoxicol; 2010; 7(3):219-31. PubMed ID: 20509767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.